Fistuloclysis Improves Liver Function and Nutritional Status in Patients with High-Output Upper Enteric Fistula

Table 5

Comparison of therapeutic efficacy in the fistuloclysis subgroups.

	Group 1	Group 2	Group 3
	(𝑛=11)	(𝑛=16)	(𝑛=8)
TB (𝜇mol/L)	■	●
DB (𝜇mol/L)	■	●
IB (𝜇mol/L)	■	●
ALT (U/L)	●	■
ALP (U/L)	■	●
GGT (U/L)
TP (g/L)	■	●
Alb (g/L)	■	●
WBC (10^9/L)
CRP (mg/L)
Fistula output (mL/day)

Group 1: patients with jejunal-ileal fistula; Group 2: patients with biliary fistula; Group 3: patients with duodenal fistula. TB: total bilirubin; DB: direct bilirubin; IB: indirect bilirubin; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGT: 𝛾-glutamyltransferase; TP: total protein; Alb: albumin; WBC: white blood cells; CRP: C-reactive protein. For each laboratory variable, patients who had the greatest changes were marked with ●. Conversely, patients with the least changes were marked with ■.